However, HSC-specific VCAM-1-deficient mice, as compared to control mice, did not show a difference with regards to steatosis, inflammation and fibrosis in two different models of NASH. This evidence concerns the gene VCAM1 and metabolic dysfunction-associated steatohepatitis.